CHM chimeric therapeutics limited

Chimeric: Media Thread, page-695

  1. 294 Posts.
    lightbulb Created with Sketch. 92
    Potential suitor for CHM is BioNTech. They have USD21bn in the bank and have stated they want to build an oncology pipeline. Augurs well for leading cell therapy companies such as CHM l!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $11.72K 2.783M

Buyers (Bids)

No. Vol. Price($)
4 2757364 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 15260220 25
View Market Depth
Last trade - 16.10pm 23/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.